Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

NCT00105989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Duloxetine
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]